GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Quick Ratio

Radiopharm Theranostics (ASX:RAD) Quick Ratio : 0.50 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Radiopharm Theranostics's quick ratio for the quarter that ended in Dec. 2023 was 0.50.

Radiopharm Theranostics has a quick ratio of 0.50. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Radiopharm Theranostics's Quick Ratio or its related term are showing as below:

ASX:RAD' s Quick Ratio Range Over the Past 10 Years
Min: 0.5   Med: 2.05   Max: 5.34
Current: 0.5

During the past 2 years, Radiopharm Theranostics's highest Quick Ratio was 5.34. The lowest was 0.50. And the median was 2.05.

ASX:RAD's Quick Ratio is ranked worse than
89% of 1546 companies
in the Biotechnology industry
Industry Median: 3.595 vs ASX:RAD: 0.50

Radiopharm Theranostics Quick Ratio Historical Data

The historical data trend for Radiopharm Theranostics's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Quick Ratio Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23
Quick Ratio
3.46 1.23

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Quick Ratio 5.34 3.46 2.05 1.23 0.50

Competitive Comparison of Radiopharm Theranostics's Quick Ratio

For the Biotechnology subindustry, Radiopharm Theranostics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Radiopharm Theranostics's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Quick Ratio falls into.



Radiopharm Theranostics Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Radiopharm Theranostics's Quick Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Quick Ratio (A: Jun. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(16.3-0)/13.229
=1.23

Radiopharm Theranostics's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(6.467-0)/12.844
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radiopharm Theranostics  (ASX:RAD) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Radiopharm Theranostics Quick Ratio Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Radiopharm Theranostics (ASX:RAD) Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines